Tech conglomerate buys Medidata for $5.7B; Alexandria teams up with Columbia for second LaunchLabs; Sobi all in on emapalumab
→ Clinical trial software provider Medidata is getting acquired in a $5.8 billion deal. The all-cash buyer, Dassault Systemes, is a French technology company that’s historically focused on 3D design and engineering. “Life science is going to go through an accelerated digitization of its own processes, basically,” Dassault CEO Bernard Charles told CNBC. Having powered operations and data analysis for hundreds of biopharma companies, CROs and researcher centers, Medidata’s platform is poised to lead the virtual transformation in the industry, he added.